- Rapid diagnostic test that helps healthcare professionals quickly determine if a patient with respiratory symptoms has:
- COVID-19
- Influenza A
- Influenza B
Purpose:
- Lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of
- Influenza A
- Influenza B nucleoprotein antigens
- SARS-CoV-2 nucleocapsid protein
- This is evaluated directly by analyzing anterior nasal swab samples of the patient
Target Users:
- This specific product is for professional use by healthcare providers
Results:
- Provides results in approximately 15 minutes
CLIA Classification:
- CLIA Waived so it can be used in a wide range of healthcare settings
Kit Contents:
- Includes
- 100 Test cassettes
- 100 Sterile swabs
- 100 Extraction buffer tubes with filter caps
- 100 Quick reference instructions
